Loading...
Natco Pharma Reports 14% Rise in Q3 Net Profit to Rs 151 Crore
LIVE TV
LOCAL
ENGLISH
For You
Entertainment
National
Sports
Markets
Business & Economy
Lifestyle
World
Astrology & Religion
Technology
Education & Jobs
Auto
Politics
Viral
Opinions
Loading more articles...
Home
Local
Live TV
Natco Pharma Q3 Net Jumps 14% to Rs 151 Cr, Declares Interim Dividend
N
News18
•
12-02-2026, 18:30
Natco Pharma Q3 Net Jumps 14% to Rs 151 Cr, Declares Interim Dividend
•
Natco Pharma's consolidated net profit rose 14% year-on-year to Rs 151 crore for Q3 ended December 31, 2025.
•
Revenue from operations increased to Rs 647 crore, up from Rs 475 crore in the same period last fiscal.
•
The company declared a third interim dividend of Rs 1.5 per share for the financial year 2025-26.
•
Board re-appointed Venkaiah Chowdary Nannapaneni as Chairman and MD for one year from April 1, 2026.
•
A wholly-owned subsidiary will be incorporated in Chile with an investment of up to USD 3 lakh.
Read Full Article on News18 in English
✦
More like this
✦
More like this
Q3 Results: Three Companies Turn Profitable from Losses; Shares to Watch for Strong Returns
M
Moneycontrol
NSE Q3 Net Profit Jumps 15% on Soaring Trading Volumes, Cost Savings
C
CNBC TV18
PNGS Reva Diamond Jewellery to launch Rs 380-cr IPO on Feb 24
N
News18
Jyothy Labs Q3 Net Profit Dips 7.2% to Rs 81.12 Cr Amid Higher Expenses
N
News18
IndiQube Spaces Reports Rs 17 Cr Loss in Dec Quarter Amid Rising Expenses
N
News18
Alembic Pharma's Gujarat Facility Clears USFDA Inspection with Two Observations
C
CNBC TV18
